Larvol Delta - Allyx-Therapeutics-Announces-Expansion-into-Parkinsons-Disease-Clinical-Research-with-Lead-Compound-ALX001-Following-IND-Acceptance

ALX-001 - Allyx Therap

https://www.globenewswire.com/news-release/2024/03/05/2840394/0/en/Allyx-Therapeutics-Announces-Expansion-into-Parkinson-s-Disease-Clinical-Research-with-Lead-Compound-ALX-001-Following-IND-Acceptance.html

Mar 5, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next